CCRB Logo

Trial History Detail on 2015-08-06

CUHK_CCT00467

2015-08-06

Prospective

KC/KE-15-0089/FR-3

Department of Ophthalmology and Visual Sciences, CUHK

Department of Ophthalmology and Visual Sciences, CUHK

N/A

Miss MAK Hoi Ching Haley

3/F, Hong Kong Eye Hospital, 147K, Argyle Street, Mongkok, Kowloon, Hong Kong

39435833

haleymak@cuhk.edu.hk

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong

Dr. YAM Cheuk Sing Jason

3/F, Hong Kong Eye Hospital, 147K, Argyle Street, Mongkok, Kowloon, Hong Kong

39435833

yamcheuksing@gmail.com

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong

Prevention of Myopia onset using ultra-low dose atropine. (PRE-MYO Study)

Prevention of Myopia onset using ultra-low dose atropine. (PRE-MYO Study)

超低濃度阿托品眼藥水在近視發病預防之研究

ultra-low dose atropine for myopia prevention study

Hong Kong

Yes

2015-07-24

atropine, myopia

Drug

atropine 0.01%Topical; normal saline 0.9% Topical

One Year

Eligible children will be randomized into 4 2 groups:
– Treatment Group: 0.01% atropine both eyes once daily
– Placebo Group: 0.9% normal saline both eyes once daily

- Age 4 to 9
- Myopia : SE > -1.0D and < +1.0 D
- Astigmatism: < 1 D
- Informed parental consent

- Ophthalmic diseases
Refractive errors: SE < -1.0D or > +1.0 D
- Previous use of treatment of atropine
- Allergy or intolerance to atropine
- Inability to attend regular follow up assessment

4

9

Both Male and Female

Interventional

Randomized

Placebo

Double-blind

Parallel

2015-08-14

128

Not Yet Recruiting

Proportion of onset of myopia and proportion of fast myopia progressor in each group.

Myopic progression is measured by change in spherical equivalent refraction (SER). Cycloplegic refraction is assessed by using an auto-refractometer. Eyeball growth is measured by change in axial length, using the IOL master.

No

2022-06-14


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.